ASP
LOXO

Adams Street Partners’s Loxo Oncology, Inc LOXO Stock Holding History

Adams Street Partners’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11,976
Closed -$314K – 21
2016
Q3 		$314K Buy
+11,976
New +$313K 0.06% 15

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adams Street Partners's LOXO Position: Q4 2016 in Review

Adams Street Partners sold out of Loxo Oncology, Inc (LOXO) in Q4 2016, closing a stake of 11,976 shares — an estimated $314K sold.

Adams Street Partners first reported a position in LOXO in Q3 2016 and held it in 1 quarter. The position peaked at $314K in Q3 2016. 86 funds tracked by Wall St. Rank hold LOXO as of Q4 2016.

  • Adams Street Partners reported no remaining Loxo Oncology, Inc position as of Q4 2016 after selling out during the quarter.
  • Adams Street Partners sold 11,976 Loxo Oncology, Inc shares in Q4 2016, an estimated $314K.
  • Adams Street Partners first reported a position in Loxo Oncology, Inc in Q3 2016 and held it in 1 quarter.
  • Adams Street Partners's Loxo Oncology, Inc position peaked at $314K in Q3 2016.
  • 86 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2016.

Based on Adams Street Partners's 13F filing for Q4 2016, filed 10 Feb 2017.